3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
10
Neoplasms
7
Cancer Pain
5
Marijuana Abuse
4
Glioblastoma
2
Squamous Cell Carcinoma of Head and Neck
1
Signs and Symptoms
1
Recurrence
1
Parasomnias
1
Pancreatic Neoplasms
1
Nausea
1
Mouth Neoplasms
1
Marijuana Use
1
Chronic Pain
1
Cachexia
1
Breast Neoplasms
1
Brain Neoplasms
1
Anxiety Disorders
1
Anorexia
1
Advanced Malignant Solid Tumor
1
Advanced Cancer
1
1- Cancer Patients During Chemotherapy Treatment
1
Interventions
Music Therapy
15
Therapeutics
13
Cognitive Behavioral Therapy
12
Methods
9
Surveys and Questionnaires
8
Standard of Care
8
Psychiatric Rehabilitation
8
Educational Status
8
Early Intervention, Educational
8
Psilocybin
7
Mindfulness
6
Ketamine
6
Hypnosis
6
Control Groups
6
Aromatherapy
6
Acupuncture Therapy
6
Mindfulness-Based Stress Reduction
5
Mindfulness-Based Cognitive Therapy
5
Massage
5
Counseling
5
Art Therapy
5
Saline Solution
4
Imagery, Psychotherapy
4
Esketamine
4
Caregivers
4
Behavior Therapy
4
Autogenic Training
4
Yoga
3
Touch
3
Therapeutic Touch
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Anxiety Disorders
×
nabiximols
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled